Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: Duke who wrote (9229)	5/7/1998 7:58:00 PM
From: Keiko	Read Replies (1) \| Respond to of 14328

Duke, What we have here is an out of court settlement in which both parties .....( SLF & TRIBY ) agree to a Summary Judgement which stipulates that Trinity Biotech is awarded 80% of the shares which were in contention ( 622,898 ) The Selfcare shares are now trading in the $ 10 dollar range and with the growth we are seeing in Selfcare, I presume these shares will continue to be held as a long term investment by Trinity..Suffice it to say, Trinity Biotech has an equity interest in a rapidly growing POC company that allows them " wiggle room" in any future acquisitions. Selfcare had gross revenues of $ 24.6 million as compared to $ 9.1 million for the same three month period last year and Selfcare continues to narrow its losses and it now appears they will come into profitability during this fiscal year. -Steve Stuart has calculated the cost basis for the majority of these Selfcare shares purchased by the managers in Dublin and the dollar appreciation of this investment is rather stunning . I applaud Dublin for their business acumen. I am however, critical of Trinity's communication skills( or lack thereof ) but at least they are consistent. Now if we are able to hold on to a Public Relations outfit for more than 90 days , I am sure we can get down to the business at hand. &&&& Cheers